JOHN F. SCHNEIDER, M.D.; H. EMERSON THOMAS, M.D.; BERNARD E. KREGER, M.D.; PATRICIA M. McNAMARA; WILLIAM B. KANNEL, M.D.
SCHNEIDER JF, THOMAS HE, KREGER BE, McNAMARA PM, KANNEL WB. Newly Acquired Left Bundle-Branch Block: The Framingham Study. Ann Intern Med. 1979;90:303-310. doi: 10.7326/0003-4819-90-3-303
Download citation file:
Published: Ann Intern Med. 1979;90(3):303-310.
The clinical implications of newly acquired left bundle-branch block (LBBB) were examined prospectively in the Framingham Study population. During 18 years of observation 55 people developed LBBB. The mean age at the onset of LBBB was 62; LBBB occurred largely in people with antecedent hypertension, cardiac enlargement, coronary heart disease, or a combination of these. Coincident with or subsequent to the onset of LBBB, 48% developed clinical coronary disease or congestive failure for the first time. Throughout the entire period of observation only 11% remained free of clinically apparent cardiovascular abnormalities. Within 10 years of the onset of LBBB, 50% had died from cardiovascular diseases. In men, the appearance of LBBB contributed independently to an increased risk of cardiovascular disease mortality. Comparison with age- and sex-matched control subjects free from LBBB confirmed that in the general adult population, newly acquired LBBB is most often a hallmark of advanced hypertensive or ischemic heart disease, or both.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only